Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI    SAN   FR0000120578

SANOFI (SAN)

2459
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo SANOFI
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

The company operates through the following segments: Pharmaceuticals, Human Vaccines and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing.

The Animal Health segment comprises the research, development, production and marketing activities for vaccines.

It offers a range of medicines and vaccines on animal species.

The company was founded in 1994 and is headquartered in Paris, France.

Number of employees : 112 128 persons.
Sales per Businesses
20122013Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals28,87182.6%27,25082.7% -5.95%
Human Vaccines3,89711.2%3,71611.3% -4.87%
Animal Health2,1796.2%1,9856% -9.77%
Sales per Regions
20122013Delta
EUR (in Million)%EUR (in Million)%
Rest of the World12,45135.6%11,44134.7% -8.83%
United States10,87331.1%10,43331.7% -4.22%
Europe (Excluding France)8,21023.5%7,93324.1% -3.49%
France2,8468.1%2,5717.8% -10.7%
North America567.001.6%573.001.7% +1.05%
Managers
NameAgeSinceTitle
Christopher A. Viehbacher542008Chief Executive Officer & Director
Serge Weinberg632009Chairman
Jérôme Contamine562009Chief Financial Officer & Executive Vice President
Elias Adam E. Zerhouni, MD632010President-Global Research & Development
Bruno Ménard-2011Chief Information Officer
Jorge Insuasty, MD-2011VP, Deputy President-Research & Development
Ji Zhang, PhD-2003Head-Research & Development Scientific Platforms
Gary J. Nabel MD, PhD-2012Chief Scientific Officer & Senior Vice President
Paul Chew, PhD-2013Chief Medical Officer & Senior Vice President
Igor Landau, MBA702004Member-Supervisory Board
Shareholders
NameShares%
L'Oréal SA 118,227,3078.95%
Norges Bank Investment Management 28,497,0582.16%
Dodge & Cox, Inc. 19,217,2001.45%
Plan d'Epargne Entreprise Sanofi Synthelabo 17,366,8921.31%
Amundi SA (Investment Management) 15,899,8651.20%
Natixis Asset Management SA 15,544,2281.18%
The Vanguard Group, Inc. 12,927,8320.98%
Lyxor International Asset Management SAS 10,584,2260.80%
BlackRock Fund Advisors 10,423,8400.79%
FIL Investments International 10,257,2550.78%
Holdings
NameShares%Valuation
Regeneron Pharmaceuticals Inc (REGN) 22,204,84122.4%7,781,797,553 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%696,570,974 USD
Sanofi India Ltd (SANOFI) 13,909,58760.4%696,570,974 USD
SANOFI (SAN) 3,632,5990.27%401,340,544 USD
Zentiva SA (ROSCD) 312,341,64974.9%118,246,301 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 2,846,0004.69%44,264,123 USD
GENFIT (GNFT) 355,2991.52%14,075,209 USD
Immune Design Corp 917,4295.82%11,018,322 USD
GlycoMimetics Inc (GLYC) 1,193,6256.32%9,728,044 USD
Proteome Sciences plc (PRM) 51,0000.024%33,593 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
GLAXOSMITHKLINE P..
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
ACTAVIS PLC
SHIRE PLC
ALLERGAN, INC.
TEVA PHARMACEUTIC..
VALEANT PHARMACEU..
REGENERON PHARMAC..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- NYSE Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF